Alzheimer’s / MCI

February 20, 2015

  • Malek-Ahmadi, M., & Nikkhahmanesh, N. (2024). Meta-analysis of Montreal Cognitive Assessment diagnostic accuracy in amnestic mild cognitive impairment. Frontiers in Psychology, 15. https://doi.org/10.3389/fpsyg.2024.1369766
  • Furneri, G., Varrasi, S., Guerrera, C.S. et al. Combining Mini-Mental State Examination and Montreal Cognitive Assessment for assessing the clinical efficacy of cholinesterase inhibitors in mild Alzheimer’s disease: a pilot study. Aging Clin Exp Res 36, 95 (2024). https://doi.org/10.1007/s40520-024-02744-4
  • Islam N, Hashem R, Gad M, et al. Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis. Alzheimer’s & Dementia : the Journal of the Alzheimer’s Association. 2023 Mar. DOI: 10.1002/alz.13040. PMID: 36934438.
  • Cersonsky, T. E. K., Mechery, S., Carper, M. M., Thompson, L., Lee, A., Alber, J., Sarkar, I. N., & Brick, L. A. D. (2022). Using the Montreal cognitive assessment to identify individuals with subtle cognitive decline. Neuropsychology. Advance online publication. https://doi.org/10.1037/neu0000820
  • Belleville, S., Cuesta, M., Bier, N., Brodeur, C., Gauthier, S., Gilbert, B., Grenier, S., Ouellet, M.-C., Viscogliosi, C. and Hudon, C. (2021), Memory training in older adults with mild cognitive impairment: Positive effects are found five years after MEMO training compared to control intervention. Alzheimer’s Dement., 17: e055187. https://doi.org/10.1002/alz.055187
  • Zhang, J. R., Cao, Y. L., Li, K., Wang, F., Wang, Y. L., Wu, J. J., … & Liu, C. F. (2021). Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson’s disease: A longitudinal study. Parkinsonism & Related Disorders, 82, 92-97.
  • Li, T., Zhang, Y., Fu, X. et al. (2021) Microstructural white matter alterations in Alzheimer’s disease and amnestic mild cognitive impairment and its diagnostic value based on diffusion kurtosis imaging: a tract-based spatial statistics study. Brain Imaging and Behavior. https://doi.org/10.1007/s11682-021-00474-
  • Shan, G., Bernick, C., Caldwell, J. Z., & Ritter, A. (2021). Machine learning methods to predict amyloid positivity using domain scores from cognitive tests. Scientific Reports, 11(1), 1-10.
  • Huo, Z., Lin, J., Bat, B. K., Chan, J. Y., Tsoi, K. K., & Yip, B. H. (2021). Diagnostic accuracy of dementia screening tools in the Chinese population: a systematic review and meta-analysis of 167 diagnostic studies. Age and Ageing.
  • Aminisani, N., Javadpour, A., Asghari-Jafarabadi, M., Jourian, M., Stephens, C., & Shamshirgaran, M. Comparison between the accuracy of Montreal Cognitive Assessment and Mini-Mental State Examination in the detection of mild cognitive impairment.
  • Clarens, M. F., Calandri, I., Helou, M. B., Martín, M. E., Méndez, P. C., & Crivelli, L. (2020). Utility of a Screening Test (MoCa) to Predict Amyloid Physiopathology in Mild Cognitive Impairment. Journal of Applied Cognitive Neuroscience, 1(1), 104-108.
  • Yue, L., Hu, D., Zhang, H., Wen, J., Wu, Y., Li, W., … & Wang, T. (2020). Prediction of 7-year’s Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment. medRxiv.
  • Akirov, A. (2020, August 14). Cerebrovascular Reactivity Predicts Cognitive Impairment Independent of AD. Retrieved September 28, 2020, from https://www.neurologyadvisor.com/topics/neurocognitive-disorders/cerebrovascular-reactivity-predicts-cognitive-impairment-independent-of-ad/
  • Zdanovskis, N., Platkājis, A., Kostiks, A., & Karelis, G. (2020). Structural Analysis of Brain Hub Region Volume and Cortical Thickness in Patients with Mild Cognitive Impairment and Dementia. Medicina,56(10), 497. doi:10.3390/medicina56100497
  • Zúñiga-Salazar, G. A., Hincapié-Arias, S. M., Salazar-Bolaños, E. E., Lara-Terán, J. J., Cáceres-Vinueza, S. V., & Duarte-Vera, Y. C. (2020). Impact of arterial hypertension on the cognitive function of patients between 45 and 65 years. Luis Vernaza Hospital, Guayaquil, Ecuador. Archivos de cardiologia de Mexico, 90(3), 284-292.
  • Sur, S., Lin, Z., Li, Y., Yasar, S., Rosenberg, P., Moghekar, A., … & Xu, C. (2020). Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology, 95(8), e962-e972.
  • Esmaeili, S., Abbasi, M. H., Malekdar, E., Joghataei, M. T., & Mehrpour, M. (2020). A Pilot Clinical Trial of Repetitive Transcranial Magnetic Stimulation in Mild Cognitive Impairment. Journal of Neurology Research.
  • Pan, I. M. Y., Lau, M. S., Mak, S. C., Hariman, K. W., Hon, S. K. H., Ching, W. K., & Chan, C. F. (2020). Staging of Dementia Severity With the Hong Kong Version of the Montreal Cognitive Assessment (HK-MoCA)’s. Alzheimer Disease & Associated Disorders.
  • Tang, Y. (2020). The MoCA as a Cognitive Screening Tool for Mild Cognitive Impairment (MCI) in Elderly Adults in China. Psychiatry Research, 113210.
  • Tung, E. E., Walston, V., & Bartley, M. (2020, June). Approach to the Older Adult With New Cognitive Symptoms. In Mayo Clinic Proceedings (Vol. 95, No. 6, pp. 1281-1292). Elsevier.
  • Wood, J. L., Weintraub, S., Coventry, C., Xu, J., Zhang, H., Rogalski, E., … & Gefen, T. Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic Versus Aphasic Dementia. Journal of the International Neuropsychological Society, 1-5.
  • Hemmy, L. S., Linskens, E. J., Silverman, P. C., Miller, M. A., Talley, K. M., Taylor, B. C., … & Fink, H. A. (2020). Brief Cognitive Tests for Distinguishing Clinical Alzheimer-Type Dementia From Mild Cognitive Impairment or Normal Cognition in Older Adults With Suspected Cognitive Impairment: A Systematic Review. Annals of Internal Medicine.
  • Liang, L., Zhao, L., Wei, Y., Mai, W., Duan, G., Su, J., … & Wilson, G. (2020). Structural and Functional Hippocampal Changes in Subjective Cognitive Decline From the Community. Frontiers in Aging Neuroscience, 12, 64.
  • Wang, H. C., Liu, N. Y., Zhang, S., Yang, Y., Wang, Z. Y., Wei, Y., … & Li, H. (2020). Clinical Experience in Treatment of Alzheimer’s Disease with Jiannao Yizhi Formula (健脑益智方) and Routine Western Medicine. Chinese Journal of Integrative Medicine, 26(3), 212-218.
  • Choi, J. B., Cho, K. J., Kim, J. C., Kim, C. H., Chung, Y. A., Jeong, H. S., … & Koh, J. S. (2019). The Effect of Daily Low Dose Tadalafil on Cerebral Perfusion and Cognition in Patients with Erectile Dysfunction and Mild Cognitive Impairment. Clinical Psychopharmacology and Neuroscience, 17(3), 432.
  • Sokołowska, N., Sokołowski, R., Polak-Szabela, N., Mazur, E., Podhorecka, M. & Kędziora-Kornatowska, K. (2018). Comparison of the effectiveness of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination in the detection of mild neurocognitive disorder in people over 60 years of age. Preliminary study. Psychiatr Pol, 52(5). Retrieved from http://www.psychiatriapolska.pl/uploads/images/PP_5_2018/ENGver843Sokolowska_PsychiatrPol2018v52i5.pdf
  • Pinto, T. C., Machado, L., Bulgacov, T. M., Rodrigues-Júnior, A. L., Costa, M. L., Ximenes, R. C., & Sougey, E. B. (2018). Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) in the elderly?. International Psychogeriatrics, 1-14.
  • Krishnan, K., Rossetti, H., Hynan, L. S., Carter, K., Falkowski, J., Lacritz, L., … & Weiner, M. (2017). Changes in Montreal Cognitive Assessment scores over time. Assessment, 24(6), 772-777.
  • Sachdev, P., MOHAN, A., TAKÁCS, A., & KONCZ, R. (2017). Forgetfulness, stress or mild dementia? Cognitive assessment of older patients.
  • Pillai, J., Khrestian, M., Bekris, L., Safar, J., & Leverenz, J. (2017). Elevated cerebrospinal fluid total Tau levels reflects predominant cortical involvement in Alzheimer’s disease (P1. 093). Neurology, 88(16 Supplement), P1-093.
  • Pirani, A., Zaccherini, D., Tulipani, C., Fabbo, A., Neviani, F., & Neri, M. (2015, December). Comparison of MMSE, MoCA and GPCog in early diagnosis of dementia. In INTERNATIONAL PSYCHOGERIATRICS (Vol. 27, pp. S106-S107). 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA: CAMBRIDGE UNIV PRESS. Poster
  • Jie, Li. “Safety and efficacy of oxiracetam for mild cognitive impairment.”Evaluation and Analysis of Drug-Use in Hospitals of China 15.6 (2015): 753-755.
  • Yuan, Linhong, et al. “The Erythrocyte Fatty Acid Profile and Cognitive Function in Old Chinese Adults.” Nutrients 8.7 (2016): 385.
  • Porges, Eric C., et al. “Frontal GABA Concentrations are Associated with Cognitive Performance in Older Adults.” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2016).
  • ZHAO, Mei, et al. “Follow-up study on patients with mild cognitive impairment by hydrogen proton magnetic resonance spectroscopy.” Chinese Journal of Contemporary Neurology and Neurosurgery 16.6 (2016): 333-337.
  • Lu, Hanna, Sandra SM Chan, and Linda CW Lam. “Associations between Intra-Individual Variability of Reaction Time and Cognitive Function in Cognitively Normal Senior Adults: Still beyond Good or Bad?.” Geriatrics 1.2 (2016): 13.
  • Kim, Kyeong Han, et al. “The Effect of Dangguijagyag-san on Mild Cognitive Impairment.” The Journal of Alternative and Complementary Medicine(2016).
  • Zhao, Weina, et al. “Comparative study of damage to cognitive function and mental behavior in patients with general paresis of the insane, Alzheimer’s disease, and frontotemporal dementia.” INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 9.4 (2016): 7374-7380.
  • Wang, Q., and Y. Sheng. “Neuropsychological characteristics of individuals with mild cognitive impairment.” European Psychiatry 33 (2016): S366.
  • Tsai, Jui-Chen, et al. “Comparing the Sensitivity, Specificity, and Predictive Values of the Montreal Cognitive Assessment and Mini-Mental State Examination When Screening People for Mild Cognitive Impairment and Dementia in Chinese population.” Archives of Psychiatric Nursing (2016).
  • Shaik, Muhammad Amin, et al. “Risk Factors of Cognitive Impairment and Brief Cognitive Tests to Predict Cognitive Performance Determined by a Formal Neuropsychological Evaluation of Primary Health Care Patients.” Journal of the American Medical Directors Association (2016).
  • Zhai, Yali, et al. “Application and Revision of Montreal Cognitive Assessment in China’s Military Retirees with Mild Cognitive Impairment.” PloS one 11.1 (2016).
  • Tyrovolas, Stefanos, et al. “Mild cognitive impairment is associated with falls among older adults: findings from the Irish Longitudinal Study on Ageing (TILDA).” Experimental gerontology 75 (2016): 42-47.
  • O’Caoimh, R., Timmons, S., & Molloy, D. W. (2016). Screening for Mild Cognitive Impairment: Comparison of “MCI Specific” Screening Instruments. Journal of Alzheimer’s Disease, (Preprint), 1-11.
  • Andersson, Anna-Eva, Hans Rosén, and Katharina S. Sunnerhagen. “Life after cardiac arrest; a very long term follow up.” Resuscitation (2015).
  • Cheung, G., Clugston, A., Croucher, M., Malone, D., Mau, E., Sims, A., & Gee, S. (2015). Performance of three cognitive screening tools in a sample of older New Zealanders. International Psychogeriatrics, 27(06), 981-989.
  • Zhou, Yan, et al. “Use of the MoCA in Detecting Early Alzheimer’s Disease in a Spanish-Speaking Population with Varied Levels of Education.” Dementia and Geriatric Cognitive Disorders Extra 5.1 (2015): 85-95.
  • Zeng, Y., et al. “[Mild cognitive impairment of stroke at subacute stage treated with acupuncture: a randomized controlled trial].” Zhongguo zhen jiu= Chinese acupuncture & moxibustion 35.10 (2015): 979-982.
  • Coleman, K. K., et al. “Detection and Differentiation of Frontotemporal Dementia and Related Disorders From Alzheimer Disease Using the Montreal Cognitive Assessment.” Alzheimer disease and associated disorders (2015).
  • Newman, John C. “Copyright and Bedside Cognitive Testing: Why We Need Alternatives to the Mini-Mental State Examination.” JAMA internal medicine (2015).
  • Tsoi, Kelvin KF, et al. “Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis.” JAMA internal medicine (2015).
  • Cecato, J. F., Martinelli, J. O., Montiel, J. M., Bartholomeu, D., & Aramaki, F. O. (2014). Discriminative Power of Montreal cognitive assessment. JMED Res, 1, 1-10.
  • McCulloch, Katie. Validation and diagnostic utility of the Mini-Mental State Examination and Montreal Cognitive Assessment in screening for dementia within a mixed clinical sample. Diss. UNIVERSITY OF HOUSTON, 2014.
  • Liew, Tau Ming, et al. “Diagnostic Utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: Major and Mild Neurocognitive Disorders.” Journal of the American Medical Directors Association (2014).
  • Cecato, J. F., Martinelli, J. E., Montiel, J. M., Bartholomeu, D., & Aramaki, F. O. (2014). Research Article Discriminative Power of Montreal Cognitive Assessment.
  • Gil, Laura, et al. “Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia.” International Journal of Geriatric Psychiatry (2014).
  • Rawle, Mark, and Andrew Larner. “MOCA SUBSCORES TO DIAGNOSE DEMENTIA SUBTYPES: INITIAL STUDY.” Journal of Neurology, Neurosurgery & Psychiatry 85.10 (2014): e4-e4.
  • Parmar, J. et al. (2014). Diagnosis and management of dementia in primary care Exploratory study. Canadian Family Physician, 60(5), 457-465.
  • Boespflug, E. L. et al. (2014). Associative Learning and Regional White Matter Deficits in Mild Cognitive Impairment. Journal of Alzheimer’s Disease.
  • Rojas-Fernandez, C. H. et al. (2014). An assessment by the Statin Cognitive Safety Task Force: 2014 update. Journal of clinical lipidology, 8(3), S5-S16.
  • Larner, A. J. (2014). Effect Size (Cohen’s d) of Cognitive Screening Instruments Examined in Pragmatic Diagnostic Accuracy Studies. Dementia and Geriatric Cognitive Disorders Extra, 4(2), 236-241.
  • Liang, P. et al. (2014). Acupuncture Stimulation of Taichong (Liv3) and Hegu (LI4) Modulates the Default Mode Network Activity in Alzheimer’s Disease. American Journal of Alzheimer’s Disease and Other Dementias, 1533317514536600.
  • Julayanont P, Brousseau M, Chertkow H, Phillips N, and Nasreddine ZS. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease. J Am Geriatr Soc. 2014 Apr;62(4):679-84.
  • Goldstein F. et al. Validity of the Montreal Cognitive Assessment as a Screen for Mild Cognitive Impairment and Dementia in African Americans. J Geriatr Psychiatry Neurol March 10, 2014.
  • Costas AS et al. Evidence of the Sensitivity of the MoCA Alternate Forms in Monitoring Cognitive Change in Early Alzheimer’s Disease . Dement Geriatr Cogn Disord February 2014;37:95-103.
  • Jung Y. et al. Amyloid burden correlates with cognitive decline in Alzheimer’s disease presenting with aphasia. European Journal of Neurology December 2013.
  • Lam B. et al. Criterion and Convergent Validity of the Montreal Cognitive Assessment with Screening and Standardized Neuropsychological Testing. J Am Geriatr Soc. 2013 Dec 9.
  • Hochstetler H. The Montreal Cognitive Assessment (MoCA) vs. The Mini-Mental State Examination (MMSE) In mild cognitive impairment and early-stage Alzheimer’s Disease”. American Neurological Association Annual Meeting. New Orleans. Oct 2013.
  • Thanupat Deetong-on et al. Prevalence and Risk Factors of Mild Cognitive Impairment in Menopausal Women at HRH Princess Maha Chakri Sirindhorn Medical Center. Thai Journal of Obstetrics and Gynecology. Vol 21, No 3 october 2013.
  • Roalf et al. Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimer’s & Dementia Volume 9, Issue 5 , Pages 529-537, September 2013.
  • Gagnon et al. Correcting the MoCA for Education: Effect on Sensitivity. Can J neurol Sci. 2013; 40: 678-683.
  • Alagiakrishnan K et al. Montreal cognitive assessment is superior to standardized mini-mental status exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed Res Int. 2013;2013:186106.
  • Wang et al. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer’s disease, and normal participants in Taiwan. Int Psychogeriatr. 2013 Aug 7:1-10. [Epub ahead of print]
  • Fujiwara et al. Physical and Sociopsychological Characteristics of Older Community Residents With Mild Cognitive Impairment as Assessed by the Japanese Version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol. 2013 Aug 6. [Epub ahead of print].
  • Jiang et al. The association between mild cognitive impairment and doing housework. Aging Ment Health. 2013 Aug 6. [Epub ahead of print]
  • Ladas et al. Eye Blink Rate as a biological marker of Mild Cognitive Impairment. Int J Psychophysiol. 2013 Aug 1. [Epub ahead of print]
  • Dong et al. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study. Int Psychogeriatr. 2013 Jul 22:1-8. [Epub ahead of print]
  • Niu et al. Non-high-density lipoprotein cholesterol and other risk factors of mild cognitive impairment among Chinese type 2 diabetic patients. J Diabetes Complications. 2013 Sep-Oct;27(5):443-6. Epub 2013 Jul 9.
  • Ismail et al. Canadian academy of geriatric psychiatry survey of brief cognitive screening instruments. Can Geriatr J. 2013 Jun 3;16(2):54-60.
  • Gluhm, S et al. Cognitive Performance on the Mini-Mental State Examination and the Montreal Cognitive Assessment Across the Healthy Adult Lifespan. Cognitive & Behavioral Neurology: March 2013 – Volume 26 – Issue 1 – p 1–5
  • Freitas S. et al.  Montreal Cognitive Assessment: validation study for mild cognitive impairment and Alzheimer disease.  Alzheimer Dis Assoc Disord. 2013 Jan;27(1) 37-43.
  • Larner et al. Comparing diagnostic accuracy of cognitive screening instruments: a weighted comparison approach. Dement Geriatr Cogn Dis Extra. 2013 Jan;3(1):60-5.
  • Boiko et al. [Possibilities of medical correction of moderate cognitive impairment]. [Article in Russian] Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(2):28-32.
  • Salma S. Soleman Hernandez et al.  Apathy, cognitive function and motor function in Alzheimer’s disease.  Dement Neuropsychol 2012 December;6(4):236-243.
  • Parunyou Julayanont, Melanie Brousseau, Michael Borrie, Howard Chertkow, Natalie Phillips, Ziad Nasreddine.  Montreal Cognitive Assessment Memory Index Score, MoCA-MIS, As a Predictor of Mild Cognitive Impairment Conversion to Alzheimer’s Disease. Abstract presented at AAIC Conference, Vancouver 2012.
  • Freitas S. et al. (2012). Montreal Cognitive Assessment (MoCA): Validation study for Mild Cognitive Impairment and Alzheimer’s disease.  Alzheimer Disease and Associated Disorders, doi: 10.1097/WAD.0b013e3182420bfe.
  • David R. Roalf et al.  Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging.  Alzheimer’s  & Dementia Journal (2012) 1-9 Article in press.  Published online 26
  • Michal Lifshitz et al.  Validation of the Hebrew Version of the MoCA Test as a Screening Instrument for the Early Detection of Mild Cognitive Impairment in Elderly Individuals.  J Geriatr Psychiatry Neurol 2012 25:155.
  • Magierska J. et al.  Clinical application of the Polish adaptation of the Montreal Cognitive Assessment (MoCA) test in screening for cognitive impairment.  Neurologia i neurochirurgia polska 2012, 46(2):130-139
  • Kriscinda A. Whitney, Brad Mossbarger, Steven M. Herman, Summer L. Ibarra.  Is the Montreal Cognitive Assessment Superior to the Mini-Mental State Examination in Detecting Subtle Cognitive Impairment Among Middle-Aged Outpatient U.S. Military Veterans?  Archives of Clinical Neuropsychology Advance Access published July 4, 2012. doi:10.1093/arclin/acs060.
  • Markwick A, Zamboni G, de Jager CA.  Profiles of cognitive subtest impairment in the Montreal Cognitive Assessment (MoCA) in a research cohort with normal Mini-Mental State Examination (MMSE) scores.  J Clin Exp Neuropsychol. 2012 Aug;34(7):750-7. Epub 2012 Apr 3.
  • Larner A.J..  Screening utility of the Montreal Cognitive Assessment (MoCA): in place of -or as well as – the MMSE? International psychogeriatrics; 2012 Mar;24(3):391-6.
  • Zhao S. et al.  A clinical memory battery for screening for amnestic mild cognitive impairment in an elderly chinese population.  Journal of clinical neuroscience, 18(6), 774-9, 2011.  Elsevier Ltd.
  • Olson R, et al.  Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life.  Journal of neuro-oncology, 105, 337-344, 2011.
  • Catherine C. Price et al. Clock Drawing in the Montreal Cognitive Assessment: Recommendations for Dementia Assessment. Dementia and Geriatric Cognitive Disorders 2011;31:179-187.
  • H. Chertkow, N. Phillips, Z. Nasreddine, V. Whitehead. Severity of mild cognitive impairment does not predict progression. Presented at the ADI Toronto, March 29, 2011.
  • Anne M. Damian et al. The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores. Dementia and Geriatric Cognitive Disorders, 2011;31:126-131.
  • Mitchell A. J., Malladi S.  Screening and case finding tools for the detection of dementia.  Part 1: evidence-based meta-analysis of multidomain tests.  The American Journal of Geriatric psychiatry, 18(9), 759-82, 2010.
  • Thissen AJ et al. Applicability and validity of the Dutch version of the Montreal Cognitive Assessment (MoCA-d) in diagnosing MCI.Gerontol Geriatr 2010 Dec;41(6):231-40.
  • Defranceso M. et al.  Conversion from MCI (Mild Cognitive Impairment) to Alzheimer’s disease: diagnostic options and predictors).  Neuropsychiatr;2010;24(2):88-98.
  • Cuttini C. et al. Initiation in Dementia: Are we detecting it? Department of Medicine, division of Geriatrics, Queen’s University,Kingston, Ontario, Canada. Abstract presented at the Canadian Conference on Dementia, Toronto, Oct. 1-3, 2010.
  • Michael Lerch et al. Could the Montreal Cognitive Assessment (MoCA) be the new “gold standard” in cognitive evaluation in geriatric patients: a clinical comparison. The Journal of the Alzheimer’s Association, Vol. 6, Issue 4, Supplement page S494, July 2010.
  • Walter Wittich, Natalie Phillips, Ziad Nasreddine, Howard Chertkow. Sensitivity and specificity of the Montreal Cognitive Assessment modified for individuals who are visually impaired. Journal of Visual Impairment & Blindness, June 2010, 104(6), 360-368.
  • Kaynak Selekler et al. Power of discrimination of Montreal Cognitive Assessment (MoCA) Scale in Turkish Patients with Mild Cognitive Impairment and Alzheimer’s Disease. Turkish Journal of Geriatrics 2010;13(3) 166-171.
  • Fujiwara Y. et al. Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the  Montreal Cognitive Assessment. Geriatr Gerontol. Int. 2010;10:225-232.
  • Guo Qi-Hao et al. Application study of quick cognitive screening test in identifying mild cognitive impairment. Neuroscience Bulletin, February 2010, 26(1):47:54.
  • Luis CA et al. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. International Journal of Geriatric Psychiatry, Online issue, October 21st, 2008, published 2009;24: 197-201.
  • Ging-Yuek R. Hsiung et al. A Pilot Study on Computerized Cognitive Training in Mild Cognitive Impairment. 5th Canadian Conference on Dementia in Toronto, Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 124.
  • Defrancesco M. et al.  Association of Mild Cognitive Impairment (MCI) and depression.  Neuropsychiatr;2009;23(3):144-50.
  • Dekkers M. et al.  Awareness in patients with mild cognitive impairment (MCI.  Tijdschr Gerontol Geriatr;2009 Feb;40(1):17-23.
  • A. Garcia et al. Apathy in Dementia: Are we detecting it? 5th Canadian Conference on Dementia in Toronto, Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 121.
  • Lisa Sweet, phd et al. The Montreal Cognitive Assessment (MoCA) in Geriatric Rehabilitation: Psychometric Properties and Association with Rehabilitation Outcomes. 5th Canadian Conference on Dementia in Toronto, Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 113.
  • Benjamin Lam et al. Validation of the Montreal Cognitive Assessment against Detailed Neuropsychological Measures. 5th Canadian Conference on Dementia in Toronto, Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 138.
  • Hemrungrojn S et al. The cognitive domains from Thai-Montreal cognitive assessment test to discriminate between amnestic MCI and mild AD from normal aging. Presented at the International Psychogeriatric Association Conference, Sept. 2009, Montreal, Quebec, Canada.
  • Koski L. et al. Measuring Cognition in a Geriatric Outpatient Clinic: Rasch Analysis of the Montreal Cognitive Assessment. Journal of Geriatric Psychiatry and Neurology, Volume 22, Number 3, Sept. 2009, page 151-160.
  • Rahman, Tomader Taha Abdel; El Gaafary, Maha Mohamed. Montreal Cognitive Assessment Arabic version: Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatrics and Gerontology International, Volume 9, Number 1, March 2009, pp. 54-61 (8).
  • JL Richard et al. Use of the MoCA in Patients Presenting to a Memory Disorders Clinic. Am J Geriatr Psychiatry 2009; 17:A112.
  • Rolf Sebaldt et al. Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: The Decide Study, The Canadian Journal of Neurological Sciences, Volume 36, Issue 5, Sept. 2009, page 599.
  • Liu-Ambrose T.Y. et al.  Increased Risk of Falling in Older Mild Cognitive Impairment.  Physical Therapy, 88(12), 1482-91, 2008.
  • Jun-Young Lee et al. Brief Screening for Mild Cognitive Impairment in Elderly Outpatient Clinic: Validation of the Korean Version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol, June 2008, 21;2:104-110.
  • Nestor SM et al. The Montreal Cognitive Assessment: a retrospective pilot study measuring longitudinal cognitive change in people with mild cognitive impairment. Presented at the Annual Meeting of the Canadian Geriatrics Society, Montreal, Canada. Canadian J of Geriatrics, Volume 11, Issue 1, March 2008, p63.
  • Smith M et al. Case finding of people with cognitive impairment using screening clinics during Alzheimer awareness month. Presented at the Annual Meeting of the Canadian Geriatrics Society, Montreal, Canada. Canadian J of Geriatrics, Volume 11, Issue 1, March 2008, p37.
  • Tobinick et al. Rapid cognitive improvement in Alzheimer’s disease following perispinal etanercept administration. Journal of Neuroinflammation, January 2008, 5:2 (e-publication).
  • Song S et al. Executive impairment and MoCA performance in mild cognitive impairment and Alzheimer’s disease. Presented at the International Neuropsychological Society Annual Meeting. Buenos Aires, Argentina. July 2-5, 2008, p. 258.
  • Wen HB et al. The application of Montreal cognitive assessment in urban Chinese residents of Beijing. Zhonghua Nei Ke Za Zhi. 2008 Jan;47(1):36-9. Chinese.
  • Shiroky et al. Can you have dementia with an MMSE score of 30. Am J of Alzheimers Dis Other Demen Oct-Nov 2007;22:5;406-415.
  • Smith T et al. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry, 2007 May; 52(5):329-32.
  • J. Reban. Montrealsky kognitivni test/MoCA/: prinos k diagnostice predemenci, Ceska Geriatricka, Revue 2006 (4):224-229.
  • Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment (MoCA): A Brief Screening Tool For Mild Cognitive Impairment. Journal of the American Geriatrics Society 53:695-699, 2005.
  • Nasreddine ZS et al. The Montreal Cognitive Assessment (MoCA): a Brief Cognitive Screening Tool for Detection of Mild Cognitive Impairment. Neurology, Volume 62, Number 7 S(5) April 2004, A132. Presented at the American Academy of Neurology Meeting, San Francisco, May 2004.
  • Nasreddine ZS et al. The Montreal Cognitive Assessment (MoCA): a Brief Cognitive Screening Tool for Detection of Mild Cognitive Iimpairment. Presented at the 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. http://www.siumed.edu/cme/AlzBrochure04.pdf, p.90, April 14-17, 2004.
  • Nasreddine ZS et al. Sensitivity and Specificity of The Montreal Cognitive Assessment (MoCA) for Detection of Mild Cognitive Deficits. Can J Neurol Sci., Volume 30, Number 2, Supplement 2/May 2003, p.30. Presented at Canadian Congress of Neurological Sciences Meeting, Quebec City, Quebec, June 2003.

Comments are closed.